Journal
/
/
Continua infusione endovenosa è la Strada del trattamento scelta per arginina-vasopressina bloccante dei recettori conivaptan nei topi per studiare Stroke-evocato Cervello Edema
Journal JoVE
Médecine
Un abonnement à JoVE est nécessaire pour voir ce contenu.  Connectez-vous ou commencez votre essai gratuit.
Journal JoVE Médecine
Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
DOI:

08:44 min

September 01, 2016

, ,

Chapitres

  • 00:05Titre
  • 00:48In Vivo Stroke Induction
  • 03:06Neurological Deficit Scoring (NDS) and Filament Removal
  • 04:14Intravenous Catheter Jugular Vein Installation for Continuous 48 Hr Treatment
  • 06:28Results: Representative Effects of Continuous I.V. or I.P. Conivaptan Treatment on Stroke-evoked Brain Edema
  • 07:18Conclusion

Summary

Traduction automatique

Our studies have revealed that the beneficial effects of conivaptan are dependent on the method of delivery after experimental stroke in mice. We have developed a research protocol for delivery of the receptor blocker via IV catheter on stroke-evoked brain edema formation in mice.

Vidéos Connexes

Read Article